{"entities":{"Q121634":{"pageid":123104,"ns":120,"title":"Item:Q121634","lastrevid":59670588,"modified":"2026-04-10T13:30:14Z","type":"item","id":"Q121634","labels":{"en":{"language":"en","value":"Subgroup\u2010specific dose finding in phase I clinical trials based on time to toxicity allowing adaptive subgroup combination"}},"descriptions":{"en":{"language":"en","value":"scientific article"}},"aliases":{},"claims":{"P31":[{"mainsnak":{"snaktype":"value","property":"P31","hash":"fd5912e4dab4b881a8eb0eb27e7893fef55176ad","datavalue":{"value":{"entity-type":"item","numeric-id":56887,"id":"Q56887"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q121634$C9EC01B4-A9E8-41E8-81A3-CF5F978D7BB9","rank":"normal"}],"P200":[{"mainsnak":{"snaktype":"value","property":"P200","hash":"24e42c0a00b628d90ed1e0d0c183fcbd8a635005","datavalue":{"value":{"entity-type":"item","numeric-id":76682,"id":"Q76682"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q121634$52AF7A5C-1F5B-47BC-82F8-4709B8DF15BE","rank":"normal"}],"P26":[{"mainsnak":{"snaktype":"value","property":"P26","hash":"4643af52b962cd2b49dc158b21805c28ed717b8c","datavalue":{"value":"17","type":"string"},"datatype":"string"},"type":"statement","id":"Q121634$F7EBCA58-607E-4D95-81F3-64E4733AEC1E","rank":"normal"}],"P25":[{"mainsnak":{"snaktype":"value","property":"P25","hash":"4e86e8a46af8405237d81676e1bf35d6310827a7","datavalue":{"value":"6","type":"string"},"datatype":"string"},"type":"statement","id":"Q121634$367B3498-6781-4357-8469-09F0DCF9F2CB","rank":"normal"}],"P128":[{"mainsnak":{"snaktype":"value","property":"P128","hash":"f20f677d59cc98c27a822893fa2cdd9363716ee7","datavalue":{"value":"734-749","type":"string"},"datatype":"string"},"type":"statement","id":"Q121634$792616DB-6F18-4573-BB35-EA3459352F0E","rank":"normal"}],"P28":[{"mainsnak":{"snaktype":"value","property":"P28","hash":"db9626bb787427167dc8802eb63a193ac3c35362","datavalue":{"value":{"time":"+2018-08-15T00:00:00Z","timezone":0,"before":0,"after":0,"precision":11,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q121634$B0368508-1481-4AE3-AC8E-4D3F91281AFF","rank":"normal"}],"P16":[{"mainsnak":{"snaktype":"value","property":"P16","hash":"b51a97aaadfb9ede1d0df61b7431edb92c609565","datavalue":{"value":{"entity-type":"item","numeric-id":121630,"id":"Q121630"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q121634$BF77F205-142A-4508-95D1-996875851056","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P16","hash":"3819759240be5406442102dda590f7b8a564153c","datavalue":{"value":{"entity-type":"item","numeric-id":121633,"id":"Q121633"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q121634$EF43EC44-ED6F-452C-9AC1-5DF5A0366799","rank":"normal"}],"P1460":[{"mainsnak":{"snaktype":"value","property":"P1460","hash":"57f7fea50d2ce1b39b695c4a1313582eed405e38","datavalue":{"value":{"entity-type":"item","numeric-id":5976449,"id":"Q5976449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q121634$A5A9FAAA-2B03-44CB-907E-1770F249D428","rank":"normal"}],"P12":[{"mainsnak":{"snaktype":"value","property":"P12","hash":"f54fd0bfa9643d0deb3c5617425a54d593d288d2","datavalue":{"value":"Q90971711","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q121634$7E06F405-7E73-446E-890D-D0C9F8EC84C7","rank":"normal"}],"P27":[{"mainsnak":{"snaktype":"value","property":"P27","hash":"9595ea4c37616483bf17c535472d26082e0acdd7","datavalue":{"value":"10.1002/PST.1891","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q121634$94CD2901-4490-477B-B9B3-21B8B39B377B","rank":"normal"}]},"sitelinks":{"mardi":{"site":"mardi","title":"Subgroup\u2010specific dose finding in phase I clinical trials based on time to toxicity allowing adaptive subgroup combination","badges":[],"url":"https://portal.mardi4nfdi.de/wiki/Subgroup%E2%80%90specific_dose_finding_in_phase_I_clinical_trials_based_on_time_to_toxicity_allowing_adaptive_subgroup_combination"}}}}}